Skip to main content
Fig. 2 | Journal of Neuroinflammation

Fig. 2

From: α-Synuclein induces prodromal symptoms of Parkinson’s disease via activating TLR2/MyD88/NF-κB pathway in Schwann cells of vagus nerve in a rat model

Fig. 2

Vagal injection of AAV-A53T leads to reduced intestinal blood flow and decreased nerve conduction velocity. A Representative image of intestinal blood flow detected by laser Doppler at 3 months post-injection. B Average intestinal blood flow. C Representative images of the left vagus nerve compound action potential detected by the electromyography system at 3 months post-injection. D Average vagus nerve conduction velocity. E Average amplitude of vagus nerve compound action potential. n = 6 per group. Data were presented as mean ± SEM. Statistical significance was analyzed using one-way ANOVA followed by Bonferroni’s multiple comparison test. **P < 0.01, ***P < 0.001, ****P < 0.0001. ns, not significant

Back to article page